82 related articles for article (PubMed ID: 1855324)
21. [Effect of ligustrazine on proliferative glomerulonephritis].
Tang X
Zhong Yao Cai; 2003 Aug; 26(8):611-2. PubMed ID: 14649206
[TBL] [Abstract][Full Text] [Related]
22. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
[TBL] [Abstract][Full Text] [Related]
23. Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
Chan MK; Kwan SY; Chan KW; Yeung CK
Am J Kidney Dis; 1987 May; 9(5):417-21. PubMed ID: 3555016
[TBL] [Abstract][Full Text] [Related]
24. IgA nephropathy: a long-term progressive study.
Orłowski T; Górski A; Rancewicz Z; Morzycka-Michalik M; Smogorzewski M; Małdyk M; Lao M; Szczesny-Nowicka B
Miner Electrolyte Metab; 1990; 16(1):54-6. PubMed ID: 2325593
[TBL] [Abstract][Full Text] [Related]
25. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
26. Concomitant therapy with prednisolone and cyclophosphamide in 17 cases with IgA nephropathy.
Katsumata Y; Hasegawa K; Hoshino K
Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):295-302. PubMed ID: 4021193
[No Abstract] [Full Text] [Related]
27. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
[TBL] [Abstract][Full Text] [Related]
28. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
Locatelli F; Vecchio LD; Pozzi C
Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
[TBL] [Abstract][Full Text] [Related]
29. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
[TBL] [Abstract][Full Text] [Related]
30. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
Cameron JS
Proc Eur Dial Transplant Assoc; 1973; 10(0):57-90. PubMed ID: 4606240
[No Abstract] [Full Text] [Related]
31. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
[TBL] [Abstract][Full Text] [Related]
32. Dipyridamole (persantin) and warfarin in the treatment of glomerulonephritis.
First MR; Goldberg B; Abrahams C
S Afr Med J; 1972 Jun; 46(25):848-9. PubMed ID: 5076072
[No Abstract] [Full Text] [Related]
33. Controlled therapeutic trial of IgA nephritis with follow-up renal biopsies.
Woo KT; Chiang GS; Yap HK; Lim CH
Ann Acad Med Singap; 1988 Apr; 17(2):226-31. PubMed ID: 3408224
[TBL] [Abstract][Full Text] [Related]
34. The treatment of glomerulonephritis.
Kincaid-Smith P
Aust N Z J Med; 1980 Jun; 10(3):340-5. PubMed ID: 6931575
[No Abstract] [Full Text] [Related]
35. Effect of dipyridamole treatment on proteinuria in pediatric renal disease.
Ueda N; Kawaguchi S; Niinomi Y; Nonoda T; Ohnishi M; Ito S; Yasaki T
Nephron; 1986; 44(3):174-9. PubMed ID: 3785481
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of IgA nephropathy].
Matousovic K; Mestecky J; Tomana M; Novak J
Vnitr Lek; 2008 Mar; 54(3):239-44. PubMed ID: 18522291
[TBL] [Abstract][Full Text] [Related]
37. Long-term effects of intensive therapy combined with tonsillectomy in patients with IgA nephropathy.
Hotta O; Taguma Y; Yoshizawa N; Oda T; Nishiyama J; Yusa N; Chiba S; Horigome I; Sudo K; Tomioka S
Acta Otolaryngol Suppl; 1996; 523():165-8. PubMed ID: 9082770
[TBL] [Abstract][Full Text] [Related]
38. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
[TBL] [Abstract][Full Text] [Related]
39. Treatment of vasculitic IgA nephropathy.
Harper L; Ferreira MA; Howie AJ; Savage CO; Richards NT; Michael J; Adu D
J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
[TBL] [Abstract][Full Text] [Related]
40. Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
Mathew TH; Kincaid-Smith P
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):727-34. PubMed ID: 4803314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
